News
Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies that target the innate immune system, announces that CEO Dr. David Bearss will serve as keynote speaker at the Med ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback